ANN ARBOR, Mich., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for companion animals, announced today that Robert Cohen, Interim Chief Executive Officer, and Stephanie Morley, President and Chief Medical Officer, will present at the upcoming H.C. Wainwright… Read More..
Preclinical data supports potential for: - Broadly applicable vaccine (young, elderly, immunocompromised) - Rapid onset of immunogenicity within 7 days of the first dose - Thermostabilized vaccine (ambient storage/shipping with no need for cold chain) - Multivalent vaccine formulation, if needed - Readily adaptable vaccine for seasonal vaccination use, if… Read More..
-Engaging with patient community and presenting overview of PRESIDIO study at The Myositis Association’s (TMA) International Annual Patient Conference -Scientific poster presentation on MISSION Phase 1b study data at 22nd Pan-American Congress of Rheumatology 2020 (PANLAR 2020) Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing… Read More..